Cargando…
The therapeutic effects of naringenin on bronchial pneumonia in children
Bronchial pneumonia in children is a common infectious disease in toddlers and infants, which may cause hyperpyrexia, pulmonary moist rales, and even respiratory failure. Traditional drugs for bronchial pneumonia in children often lead to drug resistance and side effects. Recently, naringenin has be...
Autores principales: | Yao, Wenjing, Zhang, Xiaopeng, Xu, Feng, Cao, Chunxia, Liu, Tongtong, Xue, Yuanyuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8312741/ https://www.ncbi.nlm.nih.gov/pubmed/34310866 http://dx.doi.org/10.1002/prp2.825 |
Ejemplares similares
-
Bronchial casts associated with Mycoplasma pneumoniae pneumonia in children
por: Lu, Sukun, et al.
Publicado: (2020) -
Naringenin Nano-Delivery Systems and Their Therapeutic Applications
por: Bhia, Mohammed, et al.
Publicado: (2021) -
Pharmacokinetic Comparisons of Naringenin and Naringenin-Nicotinamide Cocrystal in Rats by LC-MS/MS
por: Xu, Dan, et al.
Publicado: (2020) -
Nomogram for Prediction of Bronchial Mucus Plugs in Children with Mycoplasma pneumoniae Pneumonia
por: Xu, Xuefeng, et al.
Publicado: (2020) -
Naringenin: A Promising Therapeutic Agent against Organ Fibrosis
por: Du, Yanfei, et al.
Publicado: (2021)